Bionpharma Inc.: Drug Recall
Recall #D-0012-2025 · 09/17/2024
Class I: Dangerous
Recall Details
- Recall Number
- D-0012-2025
- Classification
- Class I
- Product Type
- Drug
- Recalling Firm
- Bionpharma Inc.
- Status
- Terminated
- Date Initiated
- 09/17/2024
- Location
- Princeton, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,980 bottles
Reason for Recall
Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.
Product Description
Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.
Distribution Pattern
Nationwide in the U.S.A.
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.